financetom
Business
financetom
/
Business
/
Karman Holdings Insider Sold Shares Worth $5,055,000, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Karman Holdings Insider Sold Shares Worth $5,055,000, According to a Recent SEC Filing
Mar 10, 2026 9:11 PM

05:19 PM EST, 12/01/2025 (MT Newswires) -- Anthony Koblinski, Director, Chief Executive Officer, on November 28, 2025, sold 75,000 shares in Karman Holdings ( KRMN ) for $5,055,000. Following the Form 4 filing with the SEC, Koblinski has control over a total of 2,465,826 common shares of the company, with 2,465,826 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/2040127/000119312525304063/xslF345X05/ownership.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Crude Oil Prices Ease for Second Day as Geopolitical Risk Premium Continues to Deflate
Crude Oil Prices Ease for Second Day as Geopolitical Risk Premium Continues to Deflate
Apr 23, 2024
09:14 AM EDT, 04/23/2024 (MT Newswires) -- Crude oil prices fell for a second day early on Tuesday as geopolitical risks ease and supply remains robust. West Texas Intermediate crude for June delivery was last seen down US$0.89 to US$81.01, the lowest in a month, while June Brent crude, the global benchmark, was down US$0.79 to US$86.21. The drop comes...
Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe
Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe
Apr 23, 2024
09:16 AM EDT, 04/23/2024 (MT Newswires) -- Bio-Techne ( TECH ) said Tuesday it has filed a lawsuit against Molecular Instruments in the Unified Patent Court in Europe over the alleged infringement of its patented RNAscope ISH technology. The company claims that Molecular Instruments' HCR 3.0 technology infringes its European Patents 1,910,572 and 2,500,439. The lawsuit aims for damages and...
Addus HomeCare 'Disappointed' with Compensation Requirement in Medicaid Final Rule; Shares Tumble Pre-Bell
Addus HomeCare 'Disappointed' with Compensation Requirement in Medicaid Final Rule; Shares Tumble Pre-Bell
Apr 23, 2024
09:18 AM EDT, 04/23/2024 (MT Newswires) -- Addus HomeCare ( ADUS ) said Tuesday it was disappointed that the Department of Health and Human Services kept a high compensation requirement in its final rule for Medicaid services. Addus shares were down 7.4% in recent premarket activity. A provision from the initial version of the rule mandates that 80% of Medicaid...
Why Is GE Aerospace Stock Trading Higher Today?
Why Is GE Aerospace Stock Trading Higher Today?
Apr 23, 2024
Post-spin-off GE Aerospace  reported first-quarter 2024 adjusted revenue growth of 15% year-over-year to $8.1 billion, with orders up 34% YoY to $11 billion. The company reported increased orders in Commercial Engines & Services and Defense & Propulsion Technologies, with revenue growth driven by pricing, spare parts volume, and higher deliveries in widebody and defense sectors. Consolidated revenue (including GE Aerospace and GE Vernova Inc. (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved